Sir Keir Starmer must urgently address problems with the NHS or risk missing out on future investment in Britain, the UK boss ...
And in January 2017 Lilly decided to walk away from the BioChaperone Lispro project for a second time. Adocia and Lilly's legal tussle intensifies as diabetes deal goes wrong | pharmaphorum Skip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback